May 10, 2021 6:30am EDT Sonnet BioTherapeutics Completes Successful GLP Repeat Dose Toxicology Study of IL12-FHAB (SON-1010) in Non-Human Primates (NHP)
May 3, 2021 6:00am EDT Sonnet BioTherapeutics Completes Licensing Agreement with New Life Therapeutics
